UPPER-AIRWAY COUGH SYNDROME

This adverse event was reported 8247 times

These drugs are most commonly taken by patients reporting UPPER-AIRWAY COUGH SYNDROME:

# Drug Count
0 ALBUTEROL SULFATE 1096
1 PREDNISONE 1010
2 MONTELUKAST SODIUM 804
3 DUPILUMAB 768
4 OMALIZUMAB 597
5 ALBUTEROL 545
6 ACETAMINOPHEN 523
7 BUDESONIDE AND FORMOTEROL FUMARATE DIHYDRATE 490
8 FLUTICASONE PROPIONATE 485
9 ADALIMUMAB 450
See all common drugs associated with UPPER-AIRWAY COUGH SYNDROME

UPPER-AIRWAY COUGH SYNDROME is most prevalent among patients taking these drugs:

# Drug Count Frequency
0 CICLESONIDE 235 0.0171
1 OSELTAMIVIR PHOSPHATE 192 0.0079
2 OMALIZUMAB 597 0.0069
3 IPRATROPIUM BROMIDE 239 0.0066
4 ROSUVASTATIN CALCIUM 194 0.0066
5 MONTELUKAST SODIUM 804 0.0065
6 AZITHROMYCIN MONOHYDRATE 264 0.0062
7 MOMETASONE FUROATE 246 0.0058
8 FLUTICASONE FUROATE AND VILANTEROL TRIFENATATE 206 0.0057
9 TIOTROPIUM BROMIDE INHALATION SPRAY 58 0.0050
See all drugs enriched for association with UPPER-AIRWAY COUGH SYNDROME

UPPER-AIRWAY COUGH SYNDROME is most prevalent among patients taking these drug classes:

# Drug class Count Frequency
0 Interleukin-5 Antagonist [EPC] 612 0.8895
1 Provitamin D2 Compound [EPC] 635 0.0213
2 Guanylate Cyclase-C Agonist [EPC] 19 0.0092
3 PCSK9 Inhibitor [EPC] 234 0.0091
4 Anti-IgE [EPC] 597 0.0069
5 Cortisol Synthesis Inhibitor [EPC] 4 0.0053
6 Pyrethroid [EPC] 9 0.0051
7 Leukotriene Receptor Antagonist [EPC] 134 0.0046
8 Peroxisome Proliferator-activated Receptor Agonist [EPC] 4 0.0044
9 Human Immunoglobulin G [EPC] 91 0.0043
See all drug classes enriched for association with UPPER-AIRWAY COUGH SYNDROME